14-day Premium Trial Subscription Try For FreeTry Free

NYSE:PFNX

Delisted

Pfenex Inc Stock News

New York Stock Exchange

Open Broker Account

$12.75

+0 (+0%)

At Close: Dec 08, 2021

Pfenex, Inc. (PFNX) CEO Eef Schimmelpennink on Q3 2019 Results - Earnings Call Transcript

12:00am, Sunday, 10'th Nov 2019

Pfenex Q3 EPS $0.09 Beats $(0.04) Estimate, Sales $15.248M Beat $9.57M Estimate

12:00am, Thursday, 07'th Nov 2019

The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight

12:00am, Sunday, 03'rd Nov 2019

Pfenex (PFNX) Reports Next Week: Wall Street Expects Earnings Growth

12:00am, Thursday, 31'st Oct 2019

Auto Loan Delinquencies At All-Time Highs

12:00am, Tuesday, 29'th Oct 2019

Cantor Fitzgerald Initiates Coverage On Pfenex with Overweight Rating, Announces $20 Price Target

12:00am, Friday, 25'th Oct 2019

The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings

12:00am, Sunday, 13'th Oct 2019

Pfenex Offers Update For PF708 Outside US: Highlights Exclusive Commercialization Deals In South Korea, Canada, Israel, Submitted Marketing Authorization App In Saudi Arabia

12:00am, Friday, 11'th Oct 2019

38 Biggest Movers From Yesterday

12:00am, Tuesday, 08'th Oct 2019

Pfenex Gets FDA Seal of Approval For Amgen's Forteo Biosimilar

12:00am, Monday, 07'th Oct 2019

The Week Ahead In Biotech: Pfenex And Clinuvel On The Radar Ahead of FDA Decisions, 2 IPOs On Deck

12:00am, Sunday, 06'th Oct 2019

34 Stocks Moving In Friday's Mid-Day Session

12:00am, Friday, 04'th Oct 2019

Biotech Stock On The Radar: FDA Verdict Ahead For Pfenex's Osteoporosis Biosimilar

12:00am, Thursday, 03'rd Oct 2019

Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates

12:00am, Monday, 30'th Sep 2019

JMP Securities Maintains Market Outperform on Pfenex, Raises Price Target to $17

12:00am, Wednesday, 11'th Sep 2019

«
1
2
3
4
5
6
7
8
9
10
11
»

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.